CMT Worldwide Secures Cement Composition Patent for Eco-Titan Poles

CMT Worldwide & Specialty Composites has received patent from the Australian Patent Authority for using cement-containing composition as a major component in eco-Titan poles.

eco-Titan pole

The patent gives protection for the composition used in Eco-Titan distribution pole plant of Dulhunty Power. The plant is based in Geelong, Australia. CMT Worldwide and Composite Materials Technology have developed this innovative material.

Using the material in the eco-Titan poles lowers carbon footprint when compared to other distribution poles. The cement composition is used for manufacturing ecologically neutral pole and offers the capability for producing more durable, stronger, lighter, and high performance poles. The eco-Titan pole using CMT’s ground breaking material has passed the latest ENA-approved fire test and the pole has been recognized as the best product. In addition, the pole underwent several other tests and performed well in accordance with safety design specifications.

The eco-Titan reduces shipping costs, offers cost competitive benefits and enhanced performance using CMT’s patent cement composition and alkali resistant rovings.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Chai, Cameron. (2019, February 09). CMT Worldwide Secures Cement Composition Patent for Eco-Titan Poles. AZoM. Retrieved on November 23, 2024 from https://www.azom.com/news.aspx?newsID=28845.

  • MLA

    Chai, Cameron. "CMT Worldwide Secures Cement Composition Patent for Eco-Titan Poles". AZoM. 23 November 2024. <https://www.azom.com/news.aspx?newsID=28845>.

  • Chicago

    Chai, Cameron. "CMT Worldwide Secures Cement Composition Patent for Eco-Titan Poles". AZoM. https://www.azom.com/news.aspx?newsID=28845. (accessed November 23, 2024).

  • Harvard

    Chai, Cameron. 2019. CMT Worldwide Secures Cement Composition Patent for Eco-Titan Poles. AZoM, viewed 23 November 2024, https://www.azom.com/news.aspx?newsID=28845.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.